[1]任英杰,王 起,陈秋生.黄芪汤加减治疗急性加重期慢性阻塞性肺疾病疗效研究[J].陕西中医,2020,(1):57-59.
　REN Yingjie,WANG Qi,CHEN Qiusheng..Observation on the curative effect of Huangqi decoction in the treatment ofacute exacerbation of chronic obstructive pulmonary disease[J].,2020,(1):57-59.
点击复制

黄芪汤加减治疗急性加重期慢性阻塞性肺疾病疗效研究
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2020年1期
页码:
57-59
栏目:
临床研究
出版日期:
2020-01-05

文章信息/Info

Title:
Observation on the curative effect of Huangqi decoction in the treatment ofacute exacerbation of chronic obstructive pulmonary disease
文章编号:
DOI:10.3969/j.issn.10007369.2020.01.015
作者:
任英杰; 王 起; 陈秋生
郑州大学附属郑州中心医院 (郑州 450000)
Author(s):
REN Yingjie; WANG Qi; CHEN Qiusheng.
Zhengzhou Central Hospital Affiated to Zhengzhou University(Zhengzhou 450000)
关键词:
慢性阻塞性肺疾病; 黄芪汤; 肺功能; 炎症因子; 动脉血氧分压; 动脉血二氧化碳分压; 肿瘤坏死因子α; 白细胞介素1β; 白细胞介素6
Keywords:
Key words 〖WT5BZ〗〖HT5”SS〗Chronic obstructive pulmonary disease; Huangqi decoction; Pulmonary function; Inflammatory factors; Arterial oxygen pressure; Arterial partial pressure of carbon dioxide; Tumor necrosis factor alpha; Interleukin 1 beta; Interleukin6
分类号:
R563.9
文献标志码:
A
摘要:
摘 要 目的：探讨黄芪汤加减治疗慢性阻塞性肺疾病急性加重期（AECOPD）的临床疗效。方法:采用随机数字表法将166例AECOPD患者随机分为常规组和观察组各83例。常规组采用常规西医方法治疗，观察组在常规组的基础上给予黄芪汤加减治疗。观察两组治疗前后第1秒用力呼气量（FEV1）、用力肺活量（FVC）、FEV1占FVC的百分比（FEV1/FVC％）、动脉血氧分压（PaO2）、动脉血二氧化碳分压（PaCO2）、肿瘤坏死因子α（TNFα）、白细胞介素1β（IL1β）、白细胞介素6（IL6）水平。结果:两组治疗后FEV1、FEV1/FVC、PaO2水平与治疗前相比较均显著升高（P＜0.05），且观察组与同期常规组相比较均显著升高（P＜0.05）；两组治疗后PaCO2、TNFα、IL1β、IL6水平与治疗前相比较均显著降低（P＜0.05），且观察组与同期常规组相比较均显著降低（P＜0.05）。结论:黄芪汤加减治疗AECOPD可降低患者炎症反应水平，改善动脉血气和肺功能，提高治疗效果，值得临床应用。
Abstract:
Abstract 〖WT5BZ〗〖HT5”SS〗Objective：To study the clinical curative effect of Huangqi decoction in the treatment of acute exacerbation of chronic obstructive pulmonary disease(AECOPD).Methods：166 patietns with AECOPD were randomly divided into the regular group and observation group with 83 patients in each group.The regular group was treated with conventional western medicine,and the observation group was given Huangqi decoction on the basis of the regular group.The lelels of forced expiratory volume (FEV1),forced vital capacity (FVC),percentage of FVC FEV1 (FEV1/FVC%),arterial oxygen pressure (PaO2),arterial partial pressure of carbon dioxide (PaCO2),tumor necrosis factor alpha (TNFalpha),interleukin1 beta (IL1 beta),white blood cell interleukin6 (IL6) in two groups before and treatment were observed.Results:The levels of FEV1,FEV1/FVC and PaO2 in two groups after treatment were significantly higher than those before treatment(P＜0.05),and those indciators of the observation were significantly higher than those of the regular group(P＜0.05).The levels of PaCO2,TNFα,IL1β and IL6 in two groups after treatment were significantly lower than those before treatment(P＜0.05),and the levels of PaCO2,TNFα,IL1β and IL6 in the observation were significantly lower than those of the regular group(P＜0.05).Conclusion:The Huangqi decoction in treatment of patients with AECOPD can can reduce the level of inflammatory reaction,improve the arterial blood gas and lung function,improve the treatment effect,and is worthy of clinical application.

参考文献/References:

[1] 柴春艳,刘娅萍.乌司他丁辅助治疗70岁以上慢性阻塞性肺病急性加重期49例疗效及其对患者炎性因子影响研究[J].陕西医学杂志,2018,47(6):790792.
[2] 梁仕勤，刘新宇，叶 焰，等.桑白皮汤加减对痰热郁肺型慢性阻塞性肺疾病急性加重期炎性指标的影响[J].安徽中医药大学学报，2017，36（1）：2629.
[3] 高培阳，周 平，张 川，等.中西医结合综合治疗脾肾阳虚和痰湿内蕴证慢性阻塞性肺疾病急性加重合并呼吸衰竭患者的临床研究[J].中国中西医结合急救杂志，2014，21（4）：245248.
[4] 慢性阻塞性肺疾病急性加重(AECOPD)诊治专家组.慢性阻塞性肺疾病急性加重(AECOPD)诊治中国专家共识(201 4年修订版)[J].国际呼吸杂志，2014，34（1）：111.
[5] 李泽庚，张念志.呼吸病中医临床精要[M].合肥：安徽科技出版社，2009：103135.
[6] 马丹女，蔡宛如.桑白皮汤配合西医治疗慢性阻塞性肺疾病（痰热郁肺证）临床疗效及生存预后观察[J].浙江中医药大学学报，2013，37（6）：691694.
[7] 徐 坡，孙 腾.大剂量生黄芪配合西药治疗呼吸机相关性肺炎疗效观察[J].陕西中医，2014，35（10）：12821284.
[8] 孙 腾，徐 坡.大剂量生黄芪对慢性阻塞性肺病患者呼吸肌肌力及以后的影响[J].陕西中医，2015，36（6）：660662.
[9] 陈 婧，方建国，吴方建，等.鱼腥草抗炎药理作用机制的研究进展[J].中草药，2014，45（2）：284289.
[10] 王雅芳，李 婷，唐正海，等.中药黄芩的化学成分及药理研究进展[J].中华中医药学刊，2015，33（1）：206211.
[11] 黄楦槟，陈金水.苏子油的药理作用研究进展[J].光明中医，2015，30（9）：20392041.
[12] 李 晶，范亚兰，林先毅.慢性阻塞性肺疾病急性加重期患者早期应用大黄通腑疗效观察[J].中国中医急症，2012，21（11）：17431744.
[13] Park SJ,Lee HA,Kim JW,et al.Platycodon grandiflorus alleviates DNCBinduced atopylike dermatitis in NC /Nga mice[J].Indian J Pharmacol,2012,44(4):469474.
[14] 刘金娜，温春秀，刘 铭，等.瓜蒌的化学成分和药理活性研究进展[J].中药材，2013，36（5）：843848.
[15] 徐 飞，林锦培，李璐璐，等.赤芍对慢性阻塞性肺疾病大鼠气道重塑的影响及机制研究[J].中华中医药杂志，2017，32（4）：17551760.

相似文献/References:

[1]杨栓柱,王 文 △,李 猛,等.千金苇茎汤合瓜蒌薤白杏仁汤治疗 慢性阻塞性肺疾病急性加重期临床研究*[J].陕西中医,2019,(5):600.
[2]王 敏,陈 阁.清热化痰祛瘀方联合西药治疗慢性阻塞性肺疾病急性 加重期患者的临床研究[J].陕西中医,2019,(5):610.
　WANG Min,CHEN Ge..Clinical study of Qingre Huatan Quyu prescription combined with western medicine in the treatment of acute exacerbation of chronic obstructive pulmonary disease[J].,2019,(1):610.
[3]李天浩,韩晨旭,王惠琴,等.基于EGFR-MUC5AC信号通路探讨参鱼化痰口服液干预慢性阻塞性肺疾病大鼠气道黏液高分泌的机制*[J].陕西中医,2019,(8):995.
　LI Tianhao,HAN Chenxu,WANG Huiqin,et al.Based on EGFR-MUC5AC signaling pathway to explore the mechanism of Shenyu Huatan oral liquid in intervention of airway mucus high secretion in COPD rats[J].,2019,(1):995.
[4]王珊珊,谭光波△.补肺汤对慢性阻塞性肺疾病肺气肿大鼠血清IFNγ、IL4表达水平影响研究*[J].陕西中医,2019,(11):1491.
　WANG Shanshan,TAN Guangbo..Effect of Bufei decoction on the expression of IFNγ and IL4 in serum of rats with chronic obstructive pulmonary disease and emphysema[J].,2019,(1):1491.
[5]彭 勇,何 江,周棉勇.黄芪汤加减治疗溃脓期肺痈临床观察*[J].陕西中医,2020,(1):66.
　PENG Yong,HE Jiang,ZHOU Mianyong..Clinical observation of Huangqi decoction in the treatment of 〖JZ〗pulmonary carbuncle in purulent period[J].,2020,(1):66.
[6]聂清华,范伏元△.射干麻黄汤联合沙丁胺醇对慢性阻塞性肺疾病患者肺功能、生活质量的影响[J].陕西中医,2020,(2):180.
　NIE Qinghua,FAN Fuyuan..Effects of Shegan Mahuang decoction and albuterol on pulmonary function and quality of life in patients with COPD[J].,2020,(1):180.
[7]刘新平,王展儒.理肺化痰通脉方治疗慢性阻塞性肺疾病急性加重期临床研究[J].陕西中医,2020,(4):484.
[8]杜沂岚,唐 敏,陈朝晖△,等.经肺腧穴中药离子导入联合振动排痰治疗慢性阻塞性肺疾病急性加重期临床疗效*[J].陕西中医,2020,(4):534.
　DU Yilan,TANG Min,CHEN Zhaohui,et al.Clinical efficacy of Chinese medicine iontophoresis via Feishu point combined with vibration sputum discarding in the treatment of AECOPD[J].,2020,(1):534.
[9]唐颖丽,谢 珊,余清萍,等.子午流注法治疗慢性阻塞性肺疾病加重期痰浊阻肺证疗效研究*[J].陕西中医,2020,(9):1311.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.039]
　TANG Yingli,XIE Shan,YU Qingping,et al.Curative effect of midnight-noon ebb-flow method on chronic obstructive pulmonary disease exacerbation with syndrome of Tanzhuo Zufei[J].,2020,(1):1311.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.039]
[10]蔡东林,孙钟和,赵益庆.慢性阻塞性肺疾病稳定期BODE指数、IL-8、TNF-α水平与肺肾气虚证相关性研究*[J].陕西中医,2020,(11):1573.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.015]

更新日期/Last Update: 2020-02-17